Streetbeat News

Regulatory

ADSK

Autodesk announced its intention to take necessary steps to regain compliance with Nasdaq's listing rules as soon as practicable. This comes after an unspecified issue that has put the company at odds with the listing requirements.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 8:32 pm

TBLT

Toughbuilt Industries, Inc. (NASDAQ:TBLT) received a Nasdaq delinquency notice for not filing its Annual Report for the fiscal year ended December 31, 2023. The company has 60 days from April 19, 2024, to submit a compliance plan to Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 8:27 pm

EMN

Eastman has been selected by the US Department of Energy to receive up to $375M investment for its second US molecular recycling project in Longview, Texas. This investment signifies a substantial commitment towards sustainable recycling technologies and positions Eastman at the forefront of the recycling innovation sector in the US.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 8:18 pm

ISPR

At the Benzinga Cannabis Capital Conference, industry leaders discussed the potential for global market expansion in the cannabis sector, highlighting the challenges and opportunities. Dr. Chanda Macias emphasized the importance of community and international scaling for women entrepreneurs, while Luna Stower of Ispire Vape Technology (NASDAQ:ISPR) discussed overcoming American biases and the significance of their Nasdaq listing. Heather Molloy spoke on the difficulties of raising capital for women in the cannabis industry and the potential for leveraging high-quality terpenes in international markets.

Portfolio Pulse from Rolando García

April 25, 2024 | 8:06 pm

ETHUSD

Consensys is suing the SEC to affirm Ethereum's status as a non-security, arguing the SEC's overreach could stifle innovation and misclassify Ethereum's ecosystem. The lawsuit seeks to protect Ethereum and its developers from being regulated as securities, emphasizing the need for regulatory clarity and industry support.

Portfolio Pulse from Murtuza Merchant

April 25, 2024 | 6:48 pm

TMUS

The FCC has approved T-Mobile's acquisition of Mint Mobile, a move that could significantly impact T-Mobile's market position by expanding its customer base and service offerings.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 6:12 pm

TTOO

T2 Biosystems has received a Notice of Allowance for a U.S. patent titled 'METHODS AND SYSTEMS FOR AMPLIFICATION IN COMPLEX SAMPLES', covering diagnostic and therapeutics methods for pathogens in whole blood. This development could enhance T2 Biosystems' product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 5:55 pm

CRPT

MSTR

MVPA

Benchmark analyst Mark Palmer reiterated a Buy rating on MicroStrategy Inc (NASDAQ:MSTR) with a $1875 price target, highlighting its significant share price increase since adopting a bitcoin acquisition strategy in August 2020. Despite facing $2.269 billion in cumulative impairment losses due to FASB rule ASC 350, the new FASB standard ASU 2023-08 allows for fair value measurement of crypto assets, potentially impacting MSTR's earnings positively if adopted early. MSTR's early adoption could increase its 2024 beginning retained earnings balance by ~$3.1 billion. MicroStrategy stock has gained 327% in the last 12 months, and investors can also gain exposure through ETFs like CRPT and MVPA.

Portfolio Pulse from Anusuya Lahiri

April 25, 2024 | 5:29 pm

SOLUSD

Eddy Lazzarin, CTO of a16zcrypto, criticized meme coins on X, arguing they distort public perception of crypto's potential, likening it to a risky casino. The debate highlights concerns over adoption, regulatory actions, and developer behavior. Mike Dudas and Jesse Walden offered counterpoints, discussing meme coins' popularity and comparing their impact to deceptive projects. The discussion reflects broader industry challenges and the search for balance between innovation and investor protection.

Portfolio Pulse from Murtuza Merchant

April 25, 2024 | 5:15 pm

CAH

The FDA has criticized Cardinal Health for not ensuring that syringes included in their convenience kits have the necessary 510(k) clearance, which has hindered the FDA's ability to assess associated risks. This oversight could impact the company's operations and regulatory compliance.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 5:12 pm